Driven by the belief that no patient should be left behind, one of the key projects for Chiesi’s Rare Disease division is alpha-mannosidosis.

Director General of Chiesi Mexico, Marco Ruggiero explains how medicine purchasing schemes have impacted the industry and Chiesi's place as a…

Early planning allowed CHRISTUS MUGUERZA to prepare for the pandemic and ensure ongoing care for non-COVID-19 patients.

With its significant economic impact, the medical devices sector seeks to strengthen its capabilities and improve care

COVID-19 highlighted the flaws and precariousness of the health system in Mexico. Public-private collaboration is the first step toward improvement.

Infrastructure, equipment and medical professionalism enable Faro del Mayab to offer specialized attention in the southeast of the country.

Strategic investment has made Grupo Neolpharma an important partner for both the public and private sectors. Learn why.

To take advantage of a blooming market, Dr. Frank Rosengaus clinic uses an aesthetics method developed by his founder. Read more about it ihere.

bioMérieux is a leader of diagnosis test development, they have used this expertise to develop state-of-the-art COVID-19 with quick, certain results